Lab & Office Space
Wet labs, coworking, offices, and shared infrastructure allow companies to start lean and expand as milestones are met.
MIC gives founders the lab space, risk capital, expertise, and a university network
needed to build high-growth science and technology companies.
MIC combines startup-ready infrastructure, capital access, operating support,
and the Mizzou network in one company-building platform.
Wet labs, coworking, offices, and shared infrastructure allow companies to start lean and expand as milestones are met.
MIC investment activity and the Centennial Investors angel network connect founders to early capital and follow-on syndicates.
Executives, mentors, and technical advisors support company formation, commercialization, hiring, and federal grant strategy, from SBIR positioning through award.
Founders can access Mizzou research capabilities, core facilities, technical talent, and a building full of other science and technology founders, advisors, and investors.
Mizzou has the research engine, Columbia has the founder energy, and MIC connects both into companies that can scale.
Founder stories, company milestones, and current builders across agtech, healthcare, life sciences, and deep tech

"MIC was essential to our success."
Katie ThompsonCo-Founder and COO, Elemental EnzymesBuilt at MIC →

"A check, and space to base our crew."
Brian WhorleyFounder and CEO, PaytientBuilt at MIC →

"Endevica Bio would not exist but for MIC."
Russ PotterfieldCEO and Executive Chair, Endevica BioBuilt at MIC →

"MIC's mentorship services have been instrumental in helping us with business planning and securing critical investment capital."
Jesse KremenakFounder and CEO, Kremenak Nanotech

"MIC is a fantastic place to build a company, providing a flexible and energizing environment and the resources you need to be successful."
Bill TurpinCo-Founder and CEO, Biography Health

"At MIC, I've found everything that I need to launch and grow a business, including mentorship, capital, and space to build our team."
Deepak SinghCo-Founder and CEO, Ponchi
Capital raises, company milestones, partnerships,
and the people building Missouri technology companies
ABK Biomedical and COR Development announced plans for a commercial GMP manufacturing facility in Ashland, near MURR and the yttrium-90 supply chain for ABK's Eye90 therapy.
Read at PR Newswire →Endevica Bio launched Kalohexis to advance melanocortin therapies for obesity and metabolic disease while Endevica continues its Phase 2 cancer cachexia program.
Read at Endevica Bio →COMO Business Times profiled Charlie Bolten and his vision for connecting Mizzou research, founder talent, and company formation in Mid-Missouri.
Read at COMO Business Times →Bring the company, the technology, or the research problem. MIC can help define the path from first experiment to fundable venture.
Start the Conversation →